← Open Payments lookup

SHEILA PATTERSON: Open Payments

NPI 1700267259 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,104 in 127 payments from 12 companies in 2025. Trend: 2023 $1,615 · 2024 $2,229 · 2025 $2,104

Food & beverage: $2,104
CompanyPaymentsAmount
ABBVIE INC.44$716
Takeda Pharmaceuticals U.S.A., Inc.12$268
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$228
Gilead Sciences, Inc.9$228
Madrigal Pharmaceuticals8$135
Ardelyx, Inc.5$107
Phathom Pharmaceuticals, Inc.12$101
QOL Medical, LLC3$80
Janssen Biotech, Inc.3$69
Ipsen Biopharmaceuticals, Inc4$67

Products named: ENTYVIO, XIFAXAN, RINVOQ, LINZESS, MAVYRET, REZDIFFRA, Livdelzi, CREON.

Industry payments across TX — which companies pay providers there.